The U.S. Food and Drug Administration has issued an emergency use authorization for a new novel coronavirus test from Abbott Laboratories. Results from the speedy test come back in as little as five ...
Abbott Laboratories’ ID Now test for the SARS-CoV-2 virus made waves when it was introduced thanks to the rapid turnaround time it promised. However, questions about the test’s performance have ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results